[1] 中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6): 572-618. [2] SHI S, TANG Y, ZHAO Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study[J]. Lancet Reg Health West Pac, 2022, 23: 100439. [3] JOGLAR J A, CHUNG M K, ARMBRUSTER A L, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation, 2024, 149(1): e1-e156. [4] MARK D B, ANSTROM K J, SHENG S, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: The CABANA Randomized Clinical Trial[J]. JAMA, 2019, 321(13): 1275-1285. [5] HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. [6] BAHNSON T D, GICZEWSKA A, MARK D B, et al. Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial[J]. Circulation, 2022, 145(11): 796-804. [7] BOYALLA V, HARLING L, SNELL A, et al. Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis[J]. Clin Res Cardiol, 2022, 111(6): 680-691. [8] CHEN Y C, VOSKOBOINIK A, GERCHE A, et al. Prevention of pathological atrial remodeling and atrial fibrillation: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2021, 77(22): 2846-2864. [9] QIU D, PENG L, GHISTA D N, et al. Left atrial remodeling mechanisms associated with atrial fibrillation[J]. Cardiovasc Eng Technol, 2021, 12(3): 361-372. [10] WIJFFELS M C, KIRCHHOF C J, DORLAND R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats[J]. Circulation, 1995, 92(7): 1954-1968. [11] SAGRIS M, VARDAS E P, THEOFILIS P, et al. Atrial fibrillation: pathogenesis, predisposing factors, and genetics[J]. Int J Mol Sci, 2021, 23(1): 6. [12] KLEIN C, BRUNEREAU J, LACROIX D, et al. Left atrial epicardial adipose tissue radiodensity is associated with electrophysiological properties of atrial myocardium in patients with atrial fibrillation[J]. Eur Radiol, 2019, 29(6): 3027-3035. [13] JI M, HE L, GAO L, et al. Assessment of left atrial structure and function by echocardiography in atrial fibrillation[J]. Diagnostics:Basel, 2022, 12(8): 1898. [14] HALAND T F, EDVARDSEN T. The role of echocardiography in management of hypertrophic cardiomyopathy[J]. J Echocardiogr, 2020, 18(2): 77-85. [15] DONS M, OLSEN F J, DE KNEGT M C, et al. Myocardial performance index by tissue Doppler echocardiography predicts adverse events in patients with atrial fibrillation[J]. Eur Heart J Cardiovasc Imaging, 2020, 21(5): 560-566. [16] GHANAYM A, ELKHASHAB K, ABDELRAZEK G, et al. Evaluation of left atrial dysfunction by speckle tracking echocardiography in systolic and diastolic heart failure[J]. Monaldi Arch Chest Dis, 2022, 92(4).DOI: 10.4081/monaldi.2022.2109. [17] YANG Z, XU M, ZHANG C, et al. A predictive model using left atrial function and B-type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation[J]. Clin Cardiol, 2021, 44(3): 407-414. [18] FROEHLICH L, MEYRE P, AESCHBACHER S, et al. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis[J]. Heart, 2019, 105(24): 1884-1891. [19] ZHUANG J, WANG Y, TANG K, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies[J]. Europace, 2012, 14(5): 638-645. [20] 褚明, 丁祥伟, 王俊宏, 等. 老年房颤患者导管射频消融疗效及复发相关因素分析[J]. 南京医科大学学报(自然科学版), 2020, 40(12): 1796-1799. [21] CASACLANG-VERZOSA G, BARNES M E, BLUME G, et al. C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly[J]. Echocardiography, 2010, 27(4): 394-399. [22] NJOKU A, KANNABHIRAN M, ARORA R, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis[J]. Europace, 2018, 20(1): 33-42. [23] HIRAI T, COTSEONES G, MAKKI N, et al. Usefulness of left ventricular diastolic function to predict recurrence of atrial fibrillation in patients with preserved left ventricular systolic function[J]. Am J Cardiol, 2014, 114(1): 65-69. [24] WAŁEK P, SIELSKI J, STARZYK K, et al. Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle[J]. Cardiol J, 2020, 27(3): 246-253. [25] CHIBA Y, IWANO H, IMAGAWA S, et al. Stiff left atrial syndrome? Don′t overlook underlying disease[J]. Eur Heart J Cardiovasc Imaging, 2023, 24(3): e44. [26] MARCHANDISE S, GARNIR Q, SCAVÉE C, et al. Prediction of left atrial fibrosis and success of catheter ablation by speckle tracking echocardiography in patients imaged in persistent atrial fibrillation[J]. Front Cardiovasc Med, 2022, 9: 856796. [27] SHI J, XU S, CHEN L, et al. Impact of left atrial sphericity index on the outcome of catheter ablation for atrial fibrillation[J]. J Cardiovasc Transl Res, 2021, 14(5): 912-920. [28] MOCHIZUKI A, YUDA S, FUJITO T, et al. Left atrial strain assessed by three-dimensional speckle tracking echocardiography predicts atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation[J]. J Echocardiogr, 2017, 15(2): 79-87. [29] KOCA H, DEMIRTAS A O, KAYPAKLı O, et al. Decreased left atrial global longitudinal strain predicts the risk of atrial fibrillation recurrence after cryoablation in paroxysmal atrial fibrillation[J]. J Interv Card Electrophysiol, 2020, 58(1): 51-59. [30] ANAGNOSTOPOULOS I, KOUSTA M, KOSSYVAKIS C, et al. The role of left atrial peak systolic strain in atrial fibrillation recurrence after catheter ablation. A systematic review and meta-analysis[J]. Acta Cardiol, 2022, 77(6): 536-544. [31] SZEGEDI N, SZÉPLAKI G, HERCZEG S, et al. Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation[J]. Europace, 2019, 21(5): 732-737. [32] SIMON J, EL MAHDIUI M, SMIT J M, et al. Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation[J]. Clin Cardiol, 2022, 45(3): 273-281. [33] PONGRATZ J, RIESS L, HARTL S, et al. Left atrial appendage volume is an independent predictor of atrial arrhythmia recurrence following cryoballoon pulmonary vein isolation in persistent atrial fibrillation[J]. Front Cardiovasc Med, 2023, 10: 1190860. [34] CHEN P, SHI Y, JU J, et al. Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation: a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2022, 9: 971848. |